IntegriChain delivers the only comprehensive commercial data and analytics platform for bio/pharma to help patients start and stay on therapy. IntegriChain empowers bio/pharma commercial operations teams to optimize distribution, patient access, and market access by leveraging insights from IntegriChain’s unmatched factory-to-patient data platform. We deliver the data and analytics foundation for the successful launch of innovative products that must balance significant therapeutic benefit with out-of-pocket costs and benefit hurdles as well as more efficient and service-oriented channel models for mature product categories. Today IntegriChain is the trusted partner for all top-10 bio/pharmaceutical companies, 16 of the top-20 life science companies, and more than 80 other suppliers, totaling more than $250 billion in annual US commerce. IntegriChain is backed by Accel-KKR, a leading Silicon Valley technology private equity firm. For more information, visit visit www.integrichain.com and our blog, and follow us on Twitter @IntegriChain and LinkedIn.
Find us at the event
- Stand number